Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH07113635B2 - Method for determining prozone in immune reaction - Google Patents
[go: Go Back, main page]

JPH07113635B2 - Method for determining prozone in immune reaction - Google Patents

Method for determining prozone in immune reaction

Info

Publication number
JPH07113635B2
JPH07113635B2 JP16494586A JP16494586A JPH07113635B2 JP H07113635 B2 JPH07113635 B2 JP H07113635B2 JP 16494586 A JP16494586 A JP 16494586A JP 16494586 A JP16494586 A JP 16494586A JP H07113635 B2 JPH07113635 B2 JP H07113635B2
Authority
JP
Japan
Prior art keywords
prozone
absorbance
antigen
ratio
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP16494586A
Other languages
Japanese (ja)
Other versions
JPS6319560A (en
Inventor
英毅 山本
順一 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Priority to JP16494586A priority Critical patent/JPH07113635B2/en
Publication of JPS6319560A publication Critical patent/JPS6319560A/en
Publication of JPH07113635B2 publication Critical patent/JPH07113635B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By Optical Means (AREA)

Description

【発明の詳細な説明】 (イ)産業上の利用分野 この発明は免疫反応におけるプロゾーン判定方法に関す
る。さらに詳しくは免疫比濁法における抗原抗体複合物
を含有する被検液のプロゾーン検出に関する。
TECHNICAL FIELD The present invention relates to a prozone determination method in immune reaction. More specifically, it relates to prozone detection of a test liquid containing an antigen-antibody complex in an immunoturbidimetric method.

(ロ)従来の技術 血清中の抗原を定量する方法として免疫比濁法がある。
これは試薬中に含有される抗体が測定目的物質である抗
原と特異的に結合しその結果生成する抗原抗体複合物に
よる被検液の濁度を吸光度として測定する方法である。
(B) Conventional technology As a method for quantifying the antigen in serum, there is an immunoturbidimetric method.
This is a method in which the turbidity of a test liquid due to an antigen-antibody complex formed as a result of an antibody contained in a reagent specifically binding to an antigen as a measurement target substance is measured as an absorbance.

(ハ)発明が解決しようとする問題点 しかしながら上記方法において、一般に濁度は抗原濃度
の上昇に伴い上昇するはずであるが、実際には高濃度側
で逆に濁度が低くなっていく現象が見られる(第5図参
照)。すなわち血清中に含まれる抗原濃度が高いのに対
し、被検液中の抗原濃度が見かけ上低く測定されること
になる現象でこれはプロゾーンと呼ばれている。このプ
ロゾーンは抗体よりも抗原が多い状態つまり抗原過剰状
態を意味し、この状態では抗原濃度は高くても抗体が不
足していて適当な大きさの抗原抗体複合物を生成できず
その結果濁度が低下することとなる。プロゾーンが生じ
ると1つの測定吸光度(見かけの吸光度)に対し2つの
抗原濃度が測定されるという問題が生じる。従って免疫
比濁法では被検液がプロゾーン域であるかどうかをチェ
ックすることが必要になる。このため従来では抗原濃度
を何段階かに希釈していき、低い濃度でより高い吸光度
を示す所がないかどうかを確認したり、反応液に再度抗
原を分注して反応させ吸光度が下がったらプロゾーン域
であると判断したり、抗体分注直後の吸光度の変化率が
ある値以上であるならばプロゾーン域であると判断する
等の方法が行われてきた。しかし前1者は希釈系列を調
製しそれぞれを反応させるので手間とコストがかかり、
また後2者は自動分析装置でないとチェックが難しくか
つ抗体分注直後の濁度の測定は液のゆらぎ等の影響で正
確な測定が困難である等それぞれに問題点がある。
(C) Problems to be Solved by the Invention However, in the above method, the turbidity should generally increase with the increase of the antigen concentration, but actually, the turbidity decreases on the high concentration side. Can be seen (see FIG. 5). That is, the concentration of antigen contained in serum is high, whereas the concentration of antigen in the test liquid is apparently low, which is called prozone. This prozone means a state in which there are more antigens than antibodies, that is, an antigen excess state.In this state, even though the antigen concentration is high, there is insufficient antibody and an antigen-antibody complex of an appropriate size cannot be produced, resulting in turbidity. The degree will be reduced. When the prozone occurs, a problem arises in which two antigen concentrations are measured for one measured absorbance (apparent absorbance). Therefore, in the immunoturbidimetric method, it is necessary to check whether the test liquid is in the prozone range. For this reason, in the past, the antigen concentration was diluted in several steps, and it was confirmed whether there was a place where higher absorbance was obtained at a low concentration, or when the antigen was again dispensed into the reaction solution to react and the absorbance decreased. Methods such as determining the region to be in the prozone region and determining that the region to be in the prozone region if the rate of change in absorbance immediately after antibody dispensing is a certain value or more have been used. However, since the former one prepares a dilution series and reacts each, it takes time and cost,
Further, the latter two have problems that they are difficult to check without an automatic analyzer and that the measurement of the turbidity immediately after the antibody is dispensed is difficult due to the influence of the fluctuation of the liquid.

この発明はかかる状況に鑑み為されたものであり、こと
に被検液がプロゾーン域にあるかどうかを簡便に判定す
る方法を提供しようとするものである。
The present invention has been made in view of such circumstances, and particularly, it aims to provide a method for easily determining whether or not a test liquid is in the prozone region.

(ニ)問題点を解決するための手段 かくしてこの発明によれば、抗原抗体複合物を含有する
被検液に光を照射してその見かけの吸光度を可視領域の
異なる2種の波長について測定し、得られた2種の吸光
度の比に基づいて被検液のプロゾーンを判定することを
特徴とする免疫反応におけるプロゾーン判定方法が提供
される。
(D) Means for Solving the Problems Thus, according to the present invention, the test liquid containing the antigen-antibody complex is irradiated with light and the apparent absorbance thereof is measured at two different wavelengths in the visible region. A method for determining a prozone in an immune reaction, characterized in that the prozone of a test liquid is determined based on the obtained ratio of two kinds of absorbance.

この発明の方法の最も特徴とする点は、異なる2種の波
長による見かけ吸光度の比が被検液中に懸濁する抗原抗
体複合物粒子の粒径のパラメータとなることを利用する
ものであり、該吸光度比と予め設定されている判定レベ
ル値との大小関係によりプロゾーンであるか否かの判定
をするものである。
The most characteristic point of the method of the present invention is that the ratio of the apparent absorbances at two different wavelengths is used as a parameter of the particle size of the antigen-antibody complex particles suspended in the test solution. Whether or not it is a pro zone is determined based on the magnitude relationship between the absorbance ratio and a preset determination level value.

プロゾーン域では抗原過剰状態になっており、抗体価の
低い試薬を使用したときには粒径の小さい抗原抗体複合
物が多数生じて抗原が過剰になっている状態のもの(第
6図(a)参照)と、抗体価の高い試薬を用いたときに
は粒径の大きい抗原抗体複合物が少数で生じている状態
のもの(第6図(b)参照)とがある。従ってプロゾー
ン域では生じている抗原抗体複合物粒子の粒径が極端に
小さいものまたは大きいものが混在していて粒径に大き
なバラツキが生じており、換言すれば生成する抗原抗体
複合物粒子の粒径がほぼ均一な状態(通常、0.5〜1.0μ
m程度)にあるときは最適な状態(第6図(c)参照)
で免疫反応が進行しており、プロゾーン域ではないこと
を意味することとなる。このことから被検液中で生成す
る抗原抗体複合物粒子の粒径変化が見かけの吸光度の比
の変化と対応することを見いだして、該吸光度の比をプ
ロゾーンの判定要素として用いていることがこの発明の
方法の特徴である。
In the prozone area, there is an excess of antigen, and when a reagent with a low antibody titer is used, a large number of antigen-antibody complexes with a small particle size are produced, resulting in an excess of antigen (Fig. 6 (a)). (See FIG. 6B), and when a reagent with a high antibody titer is used, a small number of large antigen-antibody complexes are produced (see FIG. 6 (b)). Therefore, the particle size of the antigen-antibody complex particles generated in the prozone region is extremely small or large and there is a large variation in the particle size, in other words, the generated antigen-antibody complex particles Particle size is almost uniform (usually 0.5-1.0μ
m)) is in the optimum state (see FIG. 6 (c))
It means that the immune reaction is progressing in the area other than the prozone area. From this, it was found that the change in particle size of the antigen-antibody complex particles generated in the test solution corresponds to the change in the apparent absorbance ratio, and that the absorbance ratio is used as a determination factor for the prozone. Is a feature of the method of the present invention.

異なる2種の波長に基づく吸光度の比が、被検液中に懸
濁する粒子の粒径の関数となることは次ぎにより説明さ
れる。すなわち、ある波長の光を、懸濁粒子を含む液媒
体に照射した際に得られる透過光の強度(吸光度は透過
光強度の逆数の対数)は、液媒体自体の吸収以外に懸濁
粒子の散乱作用によって減少し、液媒体自体の吸光度を
0として計算される懸濁液の吸光度は見かけ上増加す
る。この見かけ上の吸光度は懸濁粒子の散乱作用によっ
て異なり、ことに照射光の波長により散乱光強度の角度
分布が異なる傾向があるため、懸濁粒子の粒径のみなら
ず照射波長によって計測吸光度は変化する。かかる関係
下、粒径2μm以下の懸濁粒子を対象とした際に、異な
る2波長の見かけ吸光度の比が、粒径の関数となる。
It will be explained below that the ratio of the absorbances based on two different wavelengths is a function of the particle size of the particles suspended in the test liquid. That is, the intensity of transmitted light (absorbance is the logarithm of the reciprocal of the transmitted light intensity) obtained when a liquid medium containing suspended particles is irradiated with light of a certain wavelength, The absorbance of the suspension, which is decreased by the scattering effect and calculated by setting the absorbance of the liquid medium itself to 0, apparently increases. This apparent absorbance differs depending on the scattering action of the suspended particles, and in particular the angular distribution of the scattered light intensity tends to differ depending on the wavelength of the irradiation light, so the measured absorbance depends not only on the particle size of the suspended particles but also on the irradiation wavelength. Change. Under such a relationship, when a suspended particle having a particle size of 2 μm or less is targeted, a ratio of apparent absorbances of two different wavelengths becomes a function of the particle size.

この発明の方法に用いる2種の波長光は、生じる抗原抗
体複合物粒子に対して異なる散乱作用を受けるものであ
ればよく、通常、汎用されている可視光領域(約340〜7
00nm)の異なる2種の波長を選択するのが便利である。
2種の波長としては、吸光度検出器側の精度や測定粒径
範囲を適合化することにより近接した異波長のものを用
いることもできるが、通常、それぞれ340〜450nmと600
〜750nmの2種の波長を選択するのが適している。
The two types of wavelength light used in the method of the present invention may be those that undergo different scattering effects on the generated antigen-antibody complex particles, and are generally used in the visible light region (about 340 to 7).
It is convenient to select two different wavelengths (00nm).
As the two kinds of wavelengths, it is possible to use those having different wavelengths close to each other by adapting the accuracy on the side of the absorbance detector and the measurement particle size range, but usually 340 to 450 nm and 600 nm, respectively.
It is suitable to select two wavelengths of ~ 750 nm.

この発明の方法においてプロゾーンであるかどうかの判
定基準に用いられる判定レベルとしては、予め被検液を
各測定項目に応じて高感度側の波長により吸光度を測定
して検量線を作成し、この検量線のプロゾーン域境界の
濃度において、上記異なる2種の波長について吸光度を
測定して得られる比が用いられる。
As the determination level used in the determination criteria of whether it is a prozone in the method of the present invention, a calibration curve is prepared by measuring the absorbance at a wavelength on the high sensitivity side of the test liquid in advance according to each measurement item, At the concentration at the boundary of the prozone region of this calibration curve, the ratio obtained by measuring the absorbance for the two different wavelengths is used.

この発明の方法において、プロゾーンかどうかの判定
は、上記判定レベルと見かけ吸光度の比との大小を比較
することにより行われる。試薬が抗体価の高いものを使
用しているときは上記比の値が判定レベルよりも小さい
ところがプロゾーンと判定され、試薬が抗体価の低いも
のを使用しているときは上記比の値が判定レベルよりも
大きいところをプロゾーンと判定する。
In the method of the present invention, the determination as to whether the zone is prozone or not is made by comparing the magnitude of the determination level with the apparent absorbance ratio. When a reagent with a high antibody titer is used, the area where the value of the above ratio is smaller than the determination level is judged to be prozone, and when a reagent with a low antibody titer is used, the value of the above ratio is Areas larger than the judgment level are judged to be pro zones.

この発明の方法は、通常の吸光光度計、光電比色計等を
用いて行うことができ、光散乱光度計などの特殊な装置
を用いる必要はない。従って測定セルも通常の角セルを
用いることができ、セル厚も通常のものを使用すること
ができるが、多重散乱を防止すべくセル厚は薄いものを
用いるのが好ましく、通常、5〜10mm程度のものを用い
るのが適している。ただし、透過光を対象とするため多
重散乱の影響は少なくセル厚みに従来のごとき厳密さは
要求されない。
The method of the present invention can be carried out using an ordinary absorptiometer, photoelectric colorimeter, etc., and it is not necessary to use a special device such as a light scattering photometer. Therefore, as the measurement cell, a normal square cell can be used, and a normal cell thickness can be used, but it is preferable to use a thin cell thickness to prevent multiple scattering, usually 5 to 10 mm. It is suitable to use a grade. However, since the transmitted light is targeted, the influence of multiple scattering is small, and the conventional strictness of the cell thickness is not required.

ただし、この発明の方法の実施は、2波長の吸光度計測
手段を有しこれらの吸光度比を出力できる装置を用いて
行うのが適している。なお、この計測手段は連続波長光
源を用い照射光または透過光を分光して少なくとも2つ
の波長についての見かけ吸光度を計測できるよう構成さ
れたものが適している。
However, it is suitable to carry out the method of the present invention by using an apparatus that has a two-wavelength absorbance measuring means and can output the absorbance ratios thereof. It is to be noted that this measuring means is preferably configured so as to measure the apparent absorbance for at least two wavelengths by using a continuous wavelength light source to disperse the irradiation light or the transmitted light.

(ホ)作用 この発明によれば、プロゾーン境界近傍での生成する抗
原抗体複合物粒子の大きな粒径変化がプロゾーンの判定
要素となるので、粒径のパラメーターとなる2種の波長
に基づく見かけ吸光度の比を計測して、予め設定されて
いるプロゾーン境界付近の見かけ吸光度の比との大小を
比較することによりその被検液がプロゾーンであるかど
うかが判定されることとなる。
(E) Action According to the present invention, a large change in particle size of the antigen-antibody complex particles produced near the boundary of the prozone becomes a judgment factor of the prozone, and therefore, it is based on two wavelengths that are parameters of the particle size. By measuring the apparent absorbance ratio and comparing the magnitude with the preset apparent absorbance ratio in the vicinity of the prozone boundary, whether or not the test liquid is the prozone is determined.

以下実施例によりこの発明を詳細に説明するが、これに
よりこの発明は限定されるものではない。
Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.

(ヘ)実施例 第1図は、この発明の方法の実施に用いる測定装置の一
例の構成説明図である。図においてこの測定装置は、角
型測定セル(3;10mm厚)と、光源(1)、コリメータレ
ンズ(2)、集光レンズ(4)、入射スリット(5)、
回折格子(6)、2個の光電変換素子(7)(7′)、
2個のプリアンプ(8)(8′)、および2個の吸光度
算出回路(9)(9′)からなる光学測定系と、比較測
定回路(10)からなる比較器とから構成されている。そ
して素子(7)(7′)は所定の波長λ1に対応す
るように配置されている。
(F) Example FIG. 1 is a structural explanatory view of an example of a measuring apparatus used for carrying out the method of the present invention. In the figure, this measuring device comprises a prismatic measuring cell (3; 10 mm thick), a light source (1), a collimator lens (2), a condenser lens (4), an entrance slit (5),
Diffraction grating (6), two photoelectric conversion elements (7) (7 '),
It is composed of an optical measurement system including two preamplifiers (8) and (8 ') and two absorbance calculating circuits (9) and (9'), and a comparator including a comparative measurement circuit (10). The elements (7) and (7 ') are arranged so as to correspond to predetermined wavelengths λ 1 and λ 2 .

かかる装置において、光源(1)からの白色光はレンズ
(2)により平行光束となって角型測定セル(3)に照
射され、セル(3)を透過した光束を集光レンズ(4)
により入射スリット(5)に集光され、スリット(5)
を通った光は回折格子(6)によって分光される。分光
された光のうち波長λ1の光りは対応する素子
(7)(7′)に照射し、プリアンプ(8)(8′)の
出力が算出回路(9)(9′)に入るように設定されて
いる。
In such a device, the white light from the light source (1) is converted into a parallel light flux by the lens (2) and is applied to the prismatic measurement cell (3), and the light flux transmitted through the cell (3) is condensed by a condensing lens (4).
Is focused on the entrance slit (5) by the slit (5)
The light passing through is split by the diffraction grating (6). The light of wavelengths λ 1 and λ 2 of the split light is applied to the corresponding elements (7) and (7 ′), and the outputs of the preamplifiers (8) and (8 ′) are sent to the calculation circuits (9) and (9 ′). It is set to enter.

まずセル(3)に純水を入れてそのプリアンプ(8)
(8′)の出力I0(λ)、I0(λ)を算出回路
(9)(9′)に記憶する。次いで目的とする試料をセ
ル(3)に入れ、そのプリアンプ出力I(λ)、I
(λ)を用いて、算出回路(9)(9′)でそれぞれ
の吸光度: A(λ)=−log〔I(λ)/I0(λ)〕 A(λ)=−log〔I(λ)/I0(λ)〕 をそれぞれ算出する。
First, put pure water in the cell (3), and then the preamplifier (8)
The outputs I 01 ) and I 02 ) of (8 ′) are stored in the calculation circuits (9) and (9 ′). Next, the target sample is put into the cell (3), and its preamplifier output I (λ 1 ), I
Using (λ 2 ), the respective absorbances in the calculation circuits (9) and (9 ′): A (λ 1 ) = − log [I (λ 1 ) / I 01 )] A (λ 2 ) = −log [I (λ 2 ) / I 02 )] is calculated.

この出力A(λ)およびA(λ)が比測定回路(1
0)に入力され、その比A(λ)/A(λ)が出力さ
れることとなる。
The outputs A (λ 1 ) and A (λ 2 ) are the ratio measuring circuit (1
0) and the ratio A (λ 1 ) / A (λ 2 ) is output.

項目としてはIgAおよびIgGを選び、試料としては標準血
清を用いた。また、試薬としては免疫比濁用IgA、IgGお
よびネフェロメトリ用IgGを用い、免疫比濁用IgAに対し
ては9300mg/dl、IgGに対しては43000mg/dl、ネフェロメ
トリ用IgGに対しては900mg/dlの試料を用いて希釈系列
を作り、λ=340nm、λ=700nmの場合のA
(λ)、A(λ)、A(λ)/A(λ)を測定し
た。第2,3および4図に測定結果を示す。
IgA and IgG were selected as items, and standard serum was used as a sample. Further, as a reagent using immunoturbidimetric IgA, IgG and IgG for nephelometry, 9300 mg / dl for IgA for immunoturbidimetric, 43000 mg / dl for IgG, 900 mg / dl for IgG for nephelometry. A dilution series was prepared using dl samples, and A for λ 1 = 340 nm and λ 2 = 700 nm
1 ), A (λ 2 ), and A (λ 1 ) / A (λ 2 ) were measured. The measurement results are shown in Figs.

第2図において、340nmでの吸光度(A340)ではプロゾ
ーン現象が起こっているが700nmの吸光度(A700)では
まだプロゾーン現象は起こっていない。ここで吸光度の
比(A340/A700)の値を計算してプロットしたもの(×
印)が、判定レベル〔図中の点線(A340の検量線に基づ
いて算出したもの)〕以下であれば、プロゾーン現象が
起こっていると判定され、これはA340より指摘されるプ
ロゾーン域とよく一致している。
In FIG. 2, the prozone phenomenon has occurred at the absorbance at 340 nm (A 340 ), but the prozone phenomenon has not yet occurred at the absorbance at 700 nm (A 700 ). Here, the value of the ratio of absorbance (A 340 / A 700 ) was calculated and plotted (×
If the mark) is below the judgment level [dotted line in the figure (calculated based on the calibration curve of A 340 )], it is judged that the prozone phenomenon is occurring and this is indicated by A 340. It agrees well with the zone area.

第3図において、340nm、700nmの吸光度ともにプロゾー
ン現象が起こっているが、この場合も吸光度の比(A340
/A700)の値を計算してプロットしたもの(×印)が、
判定レベル〔図中の点線(A340の検量線に基づいて算出
したもの)〕以下であれば、プロゾーン現象が起こって
いると判定され、これはA340より指摘されるプロゾーン
域とよく一致している。
In Fig. 3, the prozone phenomenon occurs at both the absorbance at 340 nm and 700 nm, and in this case as well, the ratio of the absorbance (A 340
/ A 700 ) value is calculated and plotted (X mark)
If it is below the judgment level [dotted line in the figure (calculated based on the calibration curve of A 340 )], it is judged that the prozone phenomenon is occurring, which is often the prozone area pointed out by A 340. Match.

第4図において、340nm、770nmの吸光度ともにプロゾー
ン現象が起こっているが、(図の上方の○印を結ぶカー
ブが340nmによる吸光度を示す)、この場合は吸光度の
比(A340/A700)の値を計算してプロットしたもの(×
印)が、判定レベル〔図中の点線(A340の検量線に基づ
いて算出したもの)〕以上であれば、プロゾーン現象が
起こっていると判定され、これはA340より指摘されるプ
ロゾーン域とよく一致している。
In Fig. 4, the prozone phenomenon occurs at both the absorbance at 340 nm and 770 nm (the curve connecting the circles in the upper part of the figure shows the absorbance at 340 nm). In this case, the ratio of the absorbances (A 340 / A 700 ) Is calculated and plotted (×
If the mark) is above the judgment level [dotted line in the figure (calculated based on the calibration curve of A 340 )], it is judged that the prozone phenomenon is occurring and this is indicated by A 340. It agrees well with the zone area.

尚希釈系列の小さい所でもプロット値が判定レベルを上
廻る場合があるが、希釈系列が極端に小さい所では抗原
過剰状態が起ることがないのは当然であるので、この範
囲のデータは考慮に入れないで判定する(吸光度比のデ
ータは希釈倍率とともに表示されるので容易に見分けが
つく)。
The plot value may exceed the judgment level even in the small dilution series, but it is natural that the antigen excess state does not occur in the extremely small dilution series, so data in this range should be considered. Do not put in the box (the absorbance ratio data is displayed together with the dilution ratio so that it can be easily identified).

(ト)発明の効果 この発明によれば、ある濃度において異なる2波長で測
定した見かけの吸光度の比を、予め設定した判定レベル
と大小を比較することにより簡便に被検液がプロゾーン
現象を起こしているかどうかの判定ができ、希釈検体に
よるチェックまたは抗原再添加によるチェック等煩雑な
手間が不要となる。また反応の終点での吸光度を計測す
るので、常に安定した測定ができる。
(G) Effect of the Invention According to the present invention, the ratio of the apparent absorbance measured at two different wavelengths at a certain concentration is compared with a predetermined determination level to determine whether the test liquid is prozone phenomenon easily. Whether or not it is occurring can be determined, and complicated labor such as a check with a diluted sample or a check with antigen re-addition is unnecessary. Further, since the absorbance at the end point of the reaction is measured, stable measurement can be always performed.

【図面の簡単な説明】[Brief description of drawings]

第1図は、この発明の方法の実施に用いる測定装置の一
例の構成説明図、第2,3図はそれぞれ第1図の装置によ
り各標準血清を各免疫比濁用試薬で測定したときの結果
および測定値に基づいて求めた吸光度比と判定レベルを
示すグラフ図、第4図は標準血清をネフェロメトリ用試
薬で測定したときの第2図相当図、第5図はプロゾーン
現象を説明するグラフ図、第6図は被検液中に生成する
抗原抗体複合物の粒子の状態を説明する模式図である。 (1)……光源、(2)……コリメータレンズ、 (3)……角型測定セル、(4)……集光レンズ、 (5)……入射スリット、(6)……回折格子、 (7)(7′)……光電変換素子、 (8)(8′)……プリアンプ、 (9)(9′)……吸光度算出回路、 (10)……比較測定回路。
FIG. 1 is an explanatory view of the configuration of an example of a measuring apparatus used for carrying out the method of the present invention, and FIGS. 2 and 3 show the case where each standard serum is measured with each immunoturbidimetric reagent by the apparatus of FIG. FIG. 4 is a graph showing the absorbance ratio and the judgment level obtained based on the results and the measured values, FIG. 4 is a view corresponding to FIG. 2 when measuring standard serum with a reagent for nephelometry, and FIG. 5 explains the prozone phenomenon. FIG. 6 is a schematic diagram for explaining the state of particles of the antigen-antibody complex produced in the test liquid. (1) ... light source, (2) ... collimator lens, (3) ... rectangular measuring cell, (4) ... condensing lens, (5) ... incident slit, (6) ... diffraction grating, (7) (7 ') ... photoelectric conversion element, (8) (8') ... preamplifier, (9) (9 ') ... absorbance calculation circuit, (10) ... comparative measurement circuit.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】抗原抗体複合物を含有する被検液に光を照
射してその見かけの吸光度を可視領域の異なる2種の波
長について測定し、得られた2種の吸光度の比に基づい
て被検液のプロゾーンを判定することを特徴とする免疫
反応におけるプロゾーン判定方法。
1. A test solution containing an antigen-antibody complex is irradiated with light to measure its apparent absorbance with respect to two kinds of wavelengths in different visible regions, and based on the ratio of the two kinds of absorbance thus obtained. A method for determining a prozone in an immune reaction, which comprises determining the prozone of a test liquid.
JP16494586A 1986-07-14 1986-07-14 Method for determining prozone in immune reaction Expired - Lifetime JPH07113635B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16494586A JPH07113635B2 (en) 1986-07-14 1986-07-14 Method for determining prozone in immune reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16494586A JPH07113635B2 (en) 1986-07-14 1986-07-14 Method for determining prozone in immune reaction

Publications (2)

Publication Number Publication Date
JPS6319560A JPS6319560A (en) 1988-01-27
JPH07113635B2 true JPH07113635B2 (en) 1995-12-06

Family

ID=15802835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16494586A Expired - Lifetime JPH07113635B2 (en) 1986-07-14 1986-07-14 Method for determining prozone in immune reaction

Country Status (1)

Country Link
JP (1) JPH07113635B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1576843A (en) * 2003-07-07 2005-02-09 松下电器产业株式会社 Immunoassay method and immunoassay system
JP5911443B2 (en) * 2013-03-06 2016-04-27 シスメックス株式会社 Blood coagulation analyzer and blood coagulation analysis method
EP2837937A1 (en) 2013-08-15 2015-02-18 Roche Diagniostics GmbH Method for the detection of the prozone effect of photometric assays
EP3557253A4 (en) * 2016-12-15 2020-06-10 Horiba, Ltd. Method for assessing appropriateness of test substance concentration in concentration measurement using immunoagglutination reaction, and sample analysis device having processing unit for same
CN110542660A (en) * 2019-09-29 2019-12-06 迈克医疗电子有限公司 method, device and detection system for detecting prozone effect in sample reaction
CN110542662A (en) * 2019-09-29 2019-12-06 迈克医疗电子有限公司 method and device for detecting prozone effect in sample reaction and optical detection system

Also Published As

Publication number Publication date
JPS6319560A (en) 1988-01-27

Similar Documents

Publication Publication Date Title
US8673576B2 (en) Multi-wavelength analyses of sol-particle specific binding assays
US4508832A (en) Ellipsometrically measuring rate of optical change in immunoassay
US4157871A (en) System for rate immunonephelometric analysis
US5750410A (en) Method of and apparatus for immune analysis
EP0091636A2 (en) Method for the photometric determination of biological agglutination
US4988630A (en) Multiple beam laser instrument for measuring agglutination reactions
US4204837A (en) Method of rate immunonephelometric analysis
US4799796A (en) Method and apparatus for measuring immunological reaction with the aid of phase-modulation of light
EP0254430B1 (en) Light-scattering immunoassay system
JPH07113635B2 (en) Method for determining prozone in immune reaction
CA2539910A1 (en) Method and device for the detection of very small quantities of particles
JP2008008794A (en) Analyzing device
EP0786665A1 (en) Method and apparatus for immune analysis
JPS6128866A (en) Measuring method and apparatus for immuno-reaction using fluctuating intensity of light
EP0433629B1 (en) A method for the qualitative and quantitative determination of antibodies against bacterial antigens by means of the photometric measurement of agglutination
JPS61173138A (en) Method for measuring immune reaction by intensity fluctuation of light
JPS6314295B2 (en)
JPH01313737A (en) Inspection device for body to be inspected
JPS6259841A (en) Method and instrument for measuring immunoreaction using linearly polarized light
JPS6165144A (en) Instrument for measuring immune reaction using intensity fluctuation of light
JP2654698B2 (en) Immunoassay device
JPH076985B2 (en) Method for measuring antigen-antibody reaction
JPS63247644A (en) Method for measuring immune reaction
CA1112473A (en) Method and combination for detecting specific binding substances
JPS62175643A (en) Method and apparatus for measuring particle size